Skip to main content

Find Clinical Trials

Home
Conditions
Urinary Bladder Diseases

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,289 public trials 414 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Completed

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

NCT04383743

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer

NCT04053101

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations: Centre Hospitalier Universitaire de Bordeaux Bordeaux, France

Institut Bergonie Bordeaux, France

View Trial Details

Completed

Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation

NCT02170181

Conditions: Cancer Patients Receiving Stereotactic Body RTX, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +21 more
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

Study of ESG401 in Adults With Solid Tumors

NCT04892342

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +43 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China

The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Completed

Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial

NCT04534075

Conditions: Adnexal Diseases, Anus Diseases, Anus Neoplasms, +52 more
Locations: Jubileumskliniken, Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Completed

High Intensity Focused Electromagnetic Field Device for Urinary Incontinence

NCT04031014

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +16 more
Locations: Boston Urogynecology Associates Cambridge, Massachusetts, United States

View Trial Details

Completed

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

NCT06582849

Conditions: Adnexal Diseases, Anal Cancer, Anus Diseases, +117 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting

NCT03232541

Conditions: Bladder Cancer, Breast Cancer, Breast Diseases, +30 more
Locations: Sundsvall Hospital Sundsvall, Sweden

View Trial Details

Completed

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

NCT05259696

Conditions: Adnexal Diseases, Bladder Cancer, Breast Cancer, +68 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

University of Southern California Los Angeles, California, United States

Stanford Health Care Stanford, California, United States

Yale University Cancer Center New Haven, Connecticut, United States

View all 13 locations

View Trial Details

Completed

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

NCT05007106

Conditions: Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations: Alaska Womens Cancer Care ( Site 1016) Anchorage, Alaska, United States

City of Hope Comprehensive Cancer Center ( Site 1001) Duarte, California, United States

University of California, Irvine (UCI) Health - UC Irvine Me-Chao Family Comprehensive Cancer Cente Orange, California, United States

Karmanos Cancer Institute ( Site 1007) Detroit, Michigan, United States

View all 73 locations

View Trial Details